Furthermore, the THC-specific cell surface signature (CD36+CD14+PANK+) enables the identification of these cells in matched primary tumour tissues and metastases, as well as in the bloodstream of patients with lung cancer, acting as a biomarker (47). This evidence concerns the gene CD14 and lung carcinoma.